Home › NDC Lookup › RxCUI directory › RxCUI 1872261

1.5 ML brodalumab 140 MG/ML Prefilled Syringe [Siliq] — RxCUI 1872261

RxNorm drug concept · Semantic branded drug
RxCUI 1872261 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1872261
Official name1.5 ML brodalumab 140 MG/ML Prefilled Syringe [Siliq]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as1.5 ML Siliq 140 MG/ML Prefilled Syringe; SILIQ 210 MG in 1.5 ML Prefilled Syringe; Siliq 210 MG per 1.5 ML Prefilled Syringe
FDA products mapped1
Package NDCs mapped3
Reported Medicaid activity (SDUD)273 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Brodalumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Siliq is only available through a restricted program called the Siliq REMS Program because suicidal thoughts and completed suicides occurred in some patients during clinical trials...
  • Why do I have to go through a special program just to get this medication?
  • The most common things people notice are joint pain, headache, fatigue, diarrhea, sore throat, nausea, and muscle aches. Injection site reactions — like redness, bruising, or itchi...
  • What kind of side effects should I actually expect day-to-day?
📖 Read our full Brodalumab Injection guide →

🕸️ Concept Web — How 1.5 ML brodalumab 140 MG/ML Prefilled Syringe [S... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1.5 ML brodalumab 140 MG/ML Prefilled Syringe [Siliq] RxCUI 1872261

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Brodalumab 1872251
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Siliq 1872257
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Brodalumab Prefilled Syringe 1872255
    • Brodalumab Injectable Product 1872254
    • Brodalumab Prefilled Syringe [Siliq] 1872259
    • Siliq Injectable Product 1872260
    • Prefilled Syringe 721656
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Brodalumab 140 MG/ML [Siliq] SBDC · 1872258
  • Brodalumab Prefilled Syringe [Siliq] SBDF · 1872259
  • Siliq Injectable Product SBDG · 1872260
  • Siliq BN · 1872257

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 1872261 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00187-0004-02 2 SYRINGE in 1 CARTON (0187-0004-02) / 1 INJECTION in 1 SYR... Siliq Bausch Health US LLC 2017-02-15
00187-0004-03 2 INJECTION in 1 CARTON (0187-0004-03) Siliq Bausch Health US LLC 2026-06-01
00187-0004-04 1 INJECTION in 1 SYRINGE (0187-0004-04) Siliq Bausch Health US LLC 2026-06-01
Observed labelers: Bausch Health US LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.